INTRODUCING

New Generation of AI Solution Designed for the Assessment of Complex AF & AT during ablation procedures.1

Advancing Complex AF Ablation with
Volta AF-Xplorer™ II

Volta AF-Xplorer™ II brings the acute and long-term outcomes of expert electrophysiologists inside the EP lab,1 by automatically detecting dispersed electrograms, indicative of arrhythmia’s drivers.3

ADVANCED DISPERSION ANALYSIS

Real-time identification of spatio-temporal dispersion areas, now enhanced with advanced dispersion stability analysis.1,5

DIVERSIFIED DATABASE

Powered by machine and deep learning algorithms trained on a larger and more diversified database of EGMs.1

SMOOTH WORKFLOW

The new integration with GE CardioLab AltiX AI.i enables real-time digital communication while simplifying EP Lab workflow with a unified workspace.

Volta AF-Xplorer™ II provides an analysis of spatio-temporal dispersed EGMs based on dispersion time and intensity stability, that further characterize the level of dispersion and goes beyond human interpretation.1,5

‍

Non-dispersed point
Spatio-temporal dispersion point
Highly stable dispersion point

832,250

EGMs samples in the database from Europe & the USA

3X

larger database than previous version

Annotations from electrophysiologists from both geographies

Seamless Integration

The Volta AF-Xplorer™ II interface can be embedded in the CardioLab AltiX AI.i screen. This setup offers a customizable side-by-side display that supports a smooth workflow and simplifies boom integration1.

The integration provides a minimal footprint solution by removing duplicate accessories (shared keyboard, mouse and screen)1.

Maximizing Workflow Efficiency

Expanded channel capabilities allow assesment of additional bipolar electrograms1, which can improve procedural efficiency.

Increased coverage for large-profile Octaray

Volta AF-Xplorer™ II can be used in multiple configuration to adapt to your EP lab

Compatible with the major EP Recording systems, 3D navigation systems and mapping catheters, now including PFA catheters, for a tailored and intuitive workflow.1

CARTO 3
ENSITE X
AFFERA
OPAL HDx

  1. MAPPING CATHETER SCHEMATIC

  2. STANDARD DISPERSION INDICATOR: Red: dispersed electrograms. Blue: non-dispersed electrograms.

  3. HIGHLY STABLE DISPERSION INDICATOR: Dispersion highly stable in time and intensity.

  4. BOOSTER MODE: Can be activated during AT or slow AF to increase software sensitivity.

  1. MAPPING AND REFERENCE CYCLE LENGTH: Cycle length estimated from real-time recordings obtained with the mapping and coronary sinus catheter.1

  2. STANDARD DISPERSION TAGS (white)

  3. HIGHLY STABLE DISPERSION TAGS (yellow)

  1. MAPPING CATHETER SCHEMATIC

  2. STANDARD DISPERSION INDICATOR: Red: dispersed electrograms. Blue: non-dispersed electrograms.

  3. HIGHLY STABLE DISPERSION INDICATOR: Dispersion highly stable in time and intensity.

  4. AUTOTAGGING: Allows for the automated tagging of regions of interest on the mapping system (only available with EnSite X‡).

  1. BOOSTER MODE: Can be activated during AT or slow AF to increase software sensitivity.

  2. MAPPING AND REFERENCE CYCLE LENGTH: Cycle length estimated from real-time recordings obtained with the mapping and coronary sinus catheter.

  3. STANDARD DISPERSION TAGS (periwinkle)

  4. HIGHLY STABLE DISPERSION TAGS (yellow)

Now Compatible With Affera Sphere-9 One-Catheter Workflow

  1. MAPPING CATHETER SCHEMATIC

  2. STANDARD DISPERSION INDICATOR: Red: dispersed electrograms. Blue: non-dispersed electrograms.

  3. HIGHLY STABLE DISPERSION INDICATOR: Dispersion highly stable in time and intensity.

  1. BOOSTER MODE: Can be activated during AT or slow AF to increase software sensitivity.

  2. MAPPING AND REFERENCE CYCLE LENGTH: Cycle length estimated from real-time recordings obtained with the mapping and coronary sinus catheter.1

  3. DISPERSION TAGS (blue)

  1. MAPPING CATHETER SCHEMATIC

  2. STANDARD DISPERSION INDICATOR: Red: dispersed electrograms. Blue: non-dispersed electrograms.

  3. HIGHLY STABLE DISPERSION INDICATOR: Dispersion highly stable in time and intensity.

  4. BOOSTER MODE: Can be activated during AT or slow AF to increase software sensitivity.

  1. MAPPING AND REFERENCE CYCLE LENGTH: Cycle length estimated from real-time recordings obtained with the mapping and coronary sinus catheter.

  2. STANDARD DISPERSION TAGS (white)

  3. HIGHLY STABLE DISPERSION TAGS (yellow)

CLINICAL EVIDENCE

Backed by a robust clinical roadmap

Volta AF-Xplorer™ II is supported by an ambitious large-scale clinical program, adressing the most complex and underserved AF populations.

Learn more about the studies
Legal Mentions and References

ABOUT
‍
The Volta AF-Xplorer™ II system is a Medical Device manufactured by Volta Medical. This product is FDA cleared.

INDICATIONS, SAFETY & WARNINGS

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See Instructions for Use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events. All safety considerations, cautions and warnings that apply to the general use of a medical system in an operating room, also apply while using Volta AF-Xplorer™ II application. There are no known potential adverse events associated with the use of Volta AF-Xplorer™ II.

Indications: The Volta AF-Xplorer™ II assists operators in the real-time manual or automatic annotation of 3D anatomical and electrical maps of human atria for the presence of multipolar intra-cardiac atrial electrograms exhibiting spatiotemporal dispersion during atrial fibrillation or atrial tachycardia.

Contraindications: The Volta AF-Xplorer™ II has no specific contraindications.
‍
All pictures shown are for illustration purpose only.
‍
‡ Indicates a third party trademark, which is property of its respective owner.  
Volta Medical logo
Volta AF-Xplorer™ IIVoltaPlexUser ManualReferences
CareersInvestors | PressPatent NoticeContact
AI For AFib websiteCompliancePrivacy PolicyTerms of Use
Linkedin logo
Copyright © 2025 Volta Medical